Gabrielle Gendron-Lepage
Overview
Explore the profile of Gabrielle Gendron-Lepage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brunet-Ratnasingham E, Morin S, Randolph H, Labrecque M, Belair J, Lima-Barbosa R, et al.
Nat Commun
. 2024 May;
15(1):4177.
PMID: 38755196
Plasma RNAemia, delayed antibody responses and inflammation predict COVID-19 outcomes, but the mechanisms underlying these immunovirological patterns are poorly understood. We profile 782 longitudinal plasma samples from 318 hospitalized patients...
2.
Fournelle D, Mostefai F, Brunet-Ratnasingham E, Poujol R, Grenier J, Galvez J, et al.
Viruses
. 2024 Mar;
16(3).
PMID: 38543708
Throughout the SARS-CoV-2 pandemic, several variants of concern (VOCs) have been identified, many of which share recurrent mutations in the spike glycoprotein's receptor-binding domain (RBD). This region coincides with known...
3.
Ullah I, Escudie F, Scandale I, Gilani Z, Gendron-Lepage G, Gaudette F, et al.
iScience
. 2024 Feb;
27(3):109049.
PMID: 38361624
Direct acting antivirals (DAAs) represent critical tools for combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) that have escaped vaccine-elicited spike-based immunity and future coronaviruses with...
4.
Benlarbi M, Richard J, Bourassa C, Tolbert W, Chartrand-Lefebvre C, Gendron-Lepage G, et al.
J Infect Dis
. 2023 Nov;
229(3):763-774.
PMID: 38035854
Background: Chronic inflammation persists in some people living with human immunodeficiency virus (HIV) during antiretroviral therapy and is associated with premature aging. The glycoprotein 120 (gp120) subunit of HIV-1 envelope...
5.
Marchitto L, Chatterjee D, Ding S, Gendron-Lepage G, Tauzin A, Boutin M, et al.
Viruses
. 2023 Oct;
15(10).
PMID: 37896781
While mRNA SARS-CoV-2 vaccination elicits strong humoral responses in the general population, humoral responses in people living with HIV (PLWH) remain to be clarified. Here, we conducted a longitudinal study...
6.
Therrien C, Prevost J, Blais A, Turcotte S, Gendron-Lepage G, Finzi A, et al.
J Virol Methods
. 2023 Oct;
322:114836.
PMID: 37890729
No abstract available.
7.
Tauzin A, Beaudoin-Bussieres G, Benlarbi M, Nayrac M, Bo Y, Gendron-Lepage G, et al.
Viruses
. 2023 Sep;
15(9).
PMID: 37766332
While an important part of the world's population is vaccinated against SARS-CoV-2, new variants continue to emerge. We observe that even after a fifth dose of the mRNA bivalent vaccine,...
8.
Benlarbi M, Richard J, Bourassa C, Tolbert W, Chartrand-Lefebvre C, Gendron-Lepage G, et al.
medRxiv
. 2023 Aug;
PMID: 37645879
Background: Chronic inflammation persists in some people living with HIV (PLWH), even during antiretroviral therapy (ART) and is associated with premature aging. The gp120 subunit of the HIV-1 envelope glycoprotein...
9.
Marchitto L, Benlarbi M, Prevost J, Laumaea A, Descoteaux-Dinelle J, Medjahed H, et al.
mBio
. 2023 Jul;
14(4):e0078923.
PMID: 37404017
HIV-1 evades antibody-dependent cellular cytotoxicity (ADCC) responses not only by controlling Env conformation and quantity at the cell surface but also by altering NK cell activation via the downmodulation of...
10.
Ullah I, Escudie F, Scandale I, Gilani Z, Gendron-Lepage G, Gaudette F, et al.
bioRxiv
. 2023 Jul;
PMID: 37398307
Direct acting antivirals (DAAs) represent critical tools for combating SARS-CoV-2 variants of concern (VOCs) that evolve to escape spike-based immunity and future coronaviruses with pandemic potential. Here, we used bioluminescence...